# OnCo record nct05123482 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05123482/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05123482", "NCT05123482" ;
  schema:name "A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies"@en ;
  schema:alternateName "BLUESTAR"@en ;
  schema:description "A phase 1/2 trial of Puxitatug samrotecan, Rilvegostomig, Saruparib in ovarian cancer and endometrial cancer, run by AstraZeneca, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05123482/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05123482> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2021-10-18" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:drugs <https://onco.cc/drugs/puxitatug-samrotecan/>, <https://onco.cc/drugs/rilvegostomig/>, <https://onco.cc/drugs/saruparib/>, <https://onco.cc/drugs/palacaparib/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .